Calcium phosphate cement (CPC) can self-harden in vivo to form hydroxyapatite (HA) with excellent osteoconductivity. In recent studies, CPCchitosan composites are developed with high mechanical strength and washout resistance. The objectives of the present study are to optimize the setting time and mechanical properties of a CPC-chitosan composite by tailoring the chitosan content, and to evaluate the bioresorbability by using an in vitro dissolution model. Six chitosan mass fractions are tested: 0, 10, 15, 20, 25, and 30%. Specimens are immersed in solutions with pH ranging from 3.5 to 5 to simulate the acidic environments produced by osteoclasts in vivo. Dissolution is measured as the fraction of mass loss versus immersion time from 7 d to 28 d. The CPC-chitosan composite with 20% by mass chitosan has a setting time (mean AE SD; n ¼ 4) of 13 AE 1 min, significantly less than 87 AE 7 min for CPC control without chitosan ( p<0.05). The composite flexural strength (mean AE SD; n ¼ 6) was 14 AE 2 MPa, significantly higher than 4 AE 1 MPa of CPC control ( p<0.05). At an intermediate pH of 4.5, the fraction of mass loss for CPC with 20% chitosan and CPC control without chitosan are not significantly different ( p > 0.1). The dissolution rates (fraction of mass loss per day, %/d) were 1.05 for CPC control and 1.08 for CPC-chitosan. In summary, a CPC-chitosan composite is developed with fast-setting and a flexural strength three-fold of that of CPC ß 2007 SAGE Publications control without chitosan. Both materials are soluble in acidic environments, indicating that adding chitosan did not compromise the bioresorbability of CPC. The strong and resorbable CPC-chitosan composite may be useful in moderate stress-bearing craniofacial and orthopedic repairs.
INTRODUCTION
C alcium phosphate cement (CPC) has been used in craniofacial and dental procedures due to its self-hardening property and in situ formation of hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 , HA) [1] [2] [3] . The HA has a chemistry and structure similar to the minerals of a human skeleton, hence it is biocompatible and osteoconductive [4] . Compared to sintered HA implants, CPC has good shape conformability to the bone defects and can thus prevent the formation of soft tissue encapsulation [5, 6] . However, HA, like other ceramic materials, is brittle and can fracture catastrophically at a relatively small strain. As a result, CPC is not satisfactory for those applications with micromotion, such as periodontal bone repairs [5] [6] [7] . Therefore, a composite of CPC with a non-rigid and resorbable elastomeric polymer matrix is desirable for these applications. Chitosan and its derivatives are natural biopolymers that appear to be good candidates for use as an elastomeric matrix. They are biocompatible, biodegradable [8, 9] , and osteoconductive [10, 11] . Chitosan has good solubility in various acid solutions such as malic acid (which forms chitosan malate) and lactic acid (which forms chitosan lactate). Chitosans have been used in the surgical reduction of periodontal pockets [12] and as component materials for calcium phosphate compounds in various in vitro and in vivo studies [13] [14] [15] [16] [17] .
Both HA and chitosan are relatively stable in the normal physiological environment yet are resorbable under acidic conditions created by osteoclasts and other acid-producing cells [18] . The lowest reported pH for extracellular fluid is about 3, while the fluid in direct contact with the resorbing bone can have a pH of about 5 [19] . The resorption rate of the bone graft material is dependent on both the physiological environment (i.e., pH) and the properties of the materials (i.e., solubility). This rate of resorption is crucial for new bone growth. A relatively slow resorption rate is acceptable for some clinical applications such as cranioplasty, but not for other applications such as periodontal bone repairs and sinus lift procedures [20] . It has been postulated that the initial resorption rates of calcium phosphate bone graft materials are closely related to their dissolution rates in demineralizing solutions having ionic compositions mimicking the acidic environment produced by osteoclasts in vivo. Since both HA and chitosan are more soluble at lower pH, but with different solubilities, the resorbability of the composites can vary with the content of chitosan, pH, and various time periods following surgery. Therefore, it is possible to use a simple in vitro dissolution model to obtain the dissolution rates of the composites, and thus to predict their in vivo resorption behavior.
Previous work with CPC-chitosan composites investigated the effects of chitosan lactate content and powder-to-liquid ratio on the mechanical properties of the composites [21] . A recent study on macroporous CPC found a superior synergistic reinforcement by combining both chitosan and absorbable mesh [22] . However, little research has been done on the dissolution/bioresorbability of the CPC composites. The present study aims to (1) optimize the content of chitosan malate in the CPC-chitosan composites to obtain desirable setting time and mechanical properties; and (2) evaluate and predict the resorbability of the CPC-chitosan composite in vivo using a dissolution study at various acidic pH values and for various time periods.
EXPERIMENTAL

Materials Preparation
The CPC powders were prepared by thoroughly mixing equimolar amounts of tetracalcium phosphate (TTCP, Ca 4 (PO 4 ) 2 O) with dicalcium phosphate anhydrous (DCPA, CaHPO 4 ) in a micromill (Bel-Alert Products, Pequannock, NJ). The TTCP and DCPA powders were prepared using the methods described in [21] and have a median particle size of 17 and 1 mm, respectively. The CPC liquid was prepared by dissolving various amounts of chitosan-malate (hereafter abbreviated as chitosan, Lot #RNS545, technical grade, % (55-65%) by mass of chitosan, (35-45%) by mass of malic acid, viscosity 48, VANSON, Redmond, WA) into distilled water. Chitosan-malate was chosen as it was soluble in distilled water and the chitosan derived from malate salts was more soluble than the ones from other chitosan salts [23] . The chitosan/(chitosan þ water) of 10, 15, 20, 25, and 30% by mass were used. The CPC-chitosan composite (referred to as CPC-chitosan, hereafter) samples were then prepared by mixing the CPC powder with various chitosan-malate solutions at a powder/liquid (P/L) mass ratio of 2. Samples were also prepared by mixing CPC powders with distilled water without chitosan at the same P/L ratio as the control (referred to as CPC control, hereafter).
Setting Time Measurement
The setting time of the CPC composite was determined using a method described in [2, 24] . Briefly, the paste was packed into a 6 mm diameter hole in a 3 mm thick stainless steel plate, sandwiched between two glass slides, and placed in an incubator at 37 C and 100% RH. The sample was taken out of the incubator and the surface was gently rubbed with a finger [2, 24] . The sample was considered set when there was no visible powder coming off. Four samples were used for each test [2, 24] . The standard uncertainty of the measurement is 1 min.
Mechanical Testing
Flexural samples were made using stainless molds of 3 Â 4 Â 25 mm. After the assembly was placed in an incubator at 37 C and 100% RH for 4 h, the hardened sample was demolded and then immersed in a simulated physiological solution (1.15 mmol/L Ca, 1.2 mmol/L P, 133 mmol/L NaCl, 50 mmol/L HEPES, buffered to a pH of 7.4) in the same incubator for 20 h prior to being tested. A standard three-point flexural test with a span of 20 mm was used to fracture the samples. The experiments were carried out on a Universal Testing Machine (Model 5500R, Instron Corp., Canton, MA, USA) at a crosshead speed of 1 mm/min. Six samples were used for each condition. Both flexural strength and elastic modulus were determined [25] .
Dissolution Study
The samples for studying dissolution were prepared in molds of 6 Â 6 Â 3 mm. After soaking in the simulated physiological solution for 20 h, the samples were taken out and dried in a desiccator under vacuum for 24 h. Only the CPC composite with 20% chitosan and CPC control were used for the dissolution study. Five specimens were prepared for each pH. The titration system for the dissolution study was revised from an in vitro resorption model previously described [20] .
The study was carried out in a jacketed 1000 mL capacity vessel connected to a circulating bath set at 37 C, Figure 1 . A combination pH electrode (model 60110B, Extech Instruments Co., Waltham, MA) and a calcium (Ca)-ion selective electrode (Orion 97-20 Ion Plus, Thermo Electron Co., Woburn, MA) were used for triggering the titration of a hydrochloric acid (HCl) titrant and a phosphate titrant from two independent titrators (Dosimat 665, Controller, Brinkman Instruments, Westbury, NY).
First, 500 mL of a demineralizing solution (1.15 mmol/L Ca, 1.2 mmol/L P, 133 mmol/L NaCl, pH adjusted to 3-5 by adding HCl or NaOH) was added to the vessel and stable pH and Ca-electrode readings were obtained under constant stirring (18,000 Rad/s). The electrode readings were used to control the respective titrators. The samples were placed in a holder made with plexiglass and filter paper (Whatman Laboratory, Spraingfield Mill, Maidstone Kent, England) and immersed into the demineralizing solution. With the dissolution of both HA and chitosan, the pH, Ca, and P concentrations of the solution would increase. The Ca/P ratio in the solution (%1, i.e., 1.15 mmol/L Ca, 1.2 mmol/L P) would change as well since the cement dissolved at a Ca/P ratio similar to 1.62, i.e., the Ca/P ratio of the CPC cement [20] . Therefore, the automatic titration of a HCl (1 mol/L) solution and a phosphate (0.49 mmol/L P in 133 mmol/L NaCl) solution would keep both the pH and the Ca and P concentrations at constant levels assuming that the CPC would dissolve at a Ca/P ratio of 1.62. The experiments were carried out at various pHs (3) (4) (5) for up to 28 d to evaluate the effects of both pH and time. The mass of each sample was obtained before and after the immersion. In both cases, the samples were dried in a desiccator under vacuum for 24 h before weighing. The estimated standard uncertainty of the mass loss measurement is 0.2%.
Phase and Microstructure Characterization
The HA formation in the cement was determined using X-ray diffraction (XRD, Rigaku DMAX 2200, Rigaku Denki Co., Ltd. The Woodlands, TX). Scans were performed between 20 2 40 . The estimated standard uncertainty of the 2 measurement is 0.01 based on the specification of the X-ray machine. The surface morphology of the cement sample was examined using a scanning electron microscope (SEM, JSM-5300, JEOL, Peabody, MA).
RESULTS
The setting times (mean AE SD, n ¼ 4) of the CPCs are plotted versus the % by mass of chitosan in Figure 2 . Setting time was reduced with the increase of chitosan by mass. The most significant ( p<0.05) reduction occurred from (68 AE 3) min to (13 AE 1) min when the chitosan mass was increased from 15 to 20%.
The effects of chitosan mass on mechanical properties of the CPCs are shown in Figure 3 . The flexural strength first increased from (4 AE 1) MPa for CPC control to (14 AE 2) MPa for CPC with 20% by mass chitosan and then decreased. The elastic modulus (mean AE SD, n ¼ 6) varied similarly, increasing from (2.5 AE 0.5) GPa for CPC control to (4 AE 0.5) GPa at 20% chitosan and then decreasing.
The XRD patterns in Figure 4 (a) compared the phase conversion between CPC with 20% chitosan and CPC control. The HA formed in CPC-chitosan was less crystalline and the phase conversion to HA (by comparing the relative intensities of TTCP and HA peaks, the DCPA has been totally dissolved) was less complete. High magnification of their fracture surface, Figure 4 (b), showed completely different microstructures: rod-and plate-like nanocrystals (around 50-250 nm) for CPC control and nano-scaled particulates (approximately 30 nm) or agglomerates for CPC-chitosan.
The effects of pH on the dissolution of CPC, expressed as the mass loss, are shown in Figure 5 . Both cements dissolved more at pH 3.5 and the dissolution decreased with increasing pH. The CPC-chitosan lost less mass than CPC control at lower pH, and the mass loss became slightly more than CPC control after pH reached 4.5 and 5.0. The effects of immersion time on the dissolution of CPC were presented in Figure 6 . Nearly 30% of the sample was dissolved after 28 d for both cements. The mass loss increased in linear proportion with the immersion time similarly for both cements. Figure 7 compared the surface morphology of the cements after the immersion at pH 4.5 for 28 d. The CPC control exhibited a rather smooth surface with some large cracks and exfoliations, whereas CPC composite became relatively rough (porous) microstructurally, with partially dissolved chitosan scraps and HA agglomerates scattered evenly across the surface.
DISCUSSION
It has been reported that CPC-chitosan composites have both higher strength and toughness compared to their CPC counterparts [21, 26, 27] . In addition, the composites also have washout resistance with fast setting [21, 26, 27] . Although CPC with powder-to-liquid ratio of 4 was commonly used clinically, the ratio of 2 was chosen for this study for better cement cohesiveness, especially when different fractions of is clinically desirable as it allows the surgeon working time to adapt the cement paste into the bone cavity. The setting mechanism of the CPC-chitosan, however, was different from that for traditional CPC [1, 3] . When CPC is mixed with an acidic chitosan solution, like chitosanmalate solution, an increase in the pH resulting from the setting reaction of CPC [1, 3] causes the soft CPC-chitosan paste to transform into a hard mass. This leads to the initial hardening of CPC composite, which is followed by further setting between TTCP and DCPA to form HA [1, 3] . In addition to setting time, both flexural strength and elastic modulus increased with chitosan mass fraction and reached 14 MPa and 4 GPa at 20% chitosan. The strength was substantially higher (3-4 times) than that of CPC control (4 AE 1) MPa and similar to that of the CPC used clinically (around 13-16 MPa for P/L ¼ 4) [26, 27] . In comparison, the strengths of sintered porous HA and cancellous bone were 2-11 MPa and 3.5 MPa, respectively [28, 29] . Sintered porous HA, however, is not shape-conformable and requires the surgeon to carve the implant or surgical site to the desired shape, which can lead to an increase in bone loss, trauma to the surrounding tissue, and a longer surgical time [30] . Therefore, this high strength CPC composite with in situ self-hardening ability has more desirable handling characteristics for bone repair. The addition of 20% chitosan also achieved a higher elastic modulus of 4 AE 0.4 GPa than CPC control 2.5 AE 0.5 GPa, which is between the elastic modulus for cancellous bone 50-300 MPa [31] and cortical bone 7-30 GPa [32] . The improvements in both strength and modulus can be attributed to the elastomeric property of chitosan, which served as a 'glue' to fuse the HA particles together. Therefore, the sample was much denser (with less porosity) and could sustain higher stresses than CPC control. However, when the chitosan fraction was 25% or higher, both flexural strength and elastic modulus decreased. This is because at larger chitosan fractions, a larger portion of stress must be borne by the weaker chitosan matrix, as it becomes the dominant continuous phase of the composite. The reduction in crystallinity of the CPC phase at higher chitosan amount could also reduce the strength in the composite.
The XRD pattern in Figure 4 (a) showed that there was relatively more unreacted TTCP for CPC-chitosan compared to the CPC control, and the HA formed in CPC-chitosan was less crystalline. This was consistent with observed microstructures, Figure 4(b) : rod-and platelike nanocrystals in CPC control that was typical for crystalline HA [3] , whereas nano-scaled particulates or agglomerates in CPC composite were more common for amorphous or polymeric materials [33] . These nano-scaled particulates or agglomerates could be a mixture of amorphous calcium phosphate, HA nanocrystals, and chitosan. It can thus be inferred that chitosan in the composite not only impeded the dissolution of TTCP, and thus the phase conversion, but also hindered HA crystal formation and growth. This was explicable since both reactants and precipitates of the setting reaction were partially encapsulated by the initially hardened chitosan.
In addition to obtaining mechanical properties similar to bone, it is desirable for the bone graft material to be bioresorbable in vivo. Most of the resorption occurs in the initial bone healing process when the osteoclasts and other acid-producing cells generate an acidic environment around the implanted material [18] . The resorption rate is critical for the bone growth and healing, and is closely related to the dissolution rate of the biomaterial in demineralizing solutions mimicking the acidic environment in vivo [20] . Dissolution of a biomaterial is determined by its composition and solubility, and can vary with time in the case of composites consisting of materials with different solubilities. Hence, it would be useful to evaluate the dissolution rate of a biomaterial during its material design process, which can be used as a prediction for its in vivo resorption behavior.
The incorporation of 20% chitosan showed promising results in both setting and mechanical properties of CPC composite. Therefore, it was chosen as the composition for the dissolution studies. By using an in vitro dissolution model and demineralizing solutions of various pHs, the effects of pH on the dissolution of CPC control and CPC-chitosan were obtained ( Figure 5 ). Dissolution increased with pH decrease for both cements. The CPC control lost more mass than CPC-chitosan at pH 3.5 and 4, and the mass loss was slightly less than CPC-chitosan at pH 4.5 and 5. This might imply that the chitosan malate has a solubility lower than that of HA when pH is lower than 4.5. In addition, chitosan, when dissolved, formed a gel that would partially encapsulate the HA particles and therefore impede the dissolution of HA at low pH conditions. The slow dissolution of CPC-chitosan at low pH could be favorable in clinical applications as it would prevent the catastrophic disintegration of the cement at low pH.
The pH 4.5 was chosen for the 28 d dissolution study since it was considered to be closer to the physiological environment in vivo during the initial bone healing period. As shown in Figure 6 , nearly 30% of the sample was dissolved after 28 d for both cements, which was considered acceptable as new bone would grow into the graft materials during this period. Previous studies reported that CPC of similar compositions resorbed nearly completely and were replaced by new bone within six months after the CPC was used to fill the periodontal bone defects [34] and in reconstruction of alveolar ridge in dogs [35] . Therefore, a pH of 5 or even 5.5 might be more appropriate to simulate the physiological condition in vivo, which will be further investigated in future studies. Dissolution of both the cements remained almost identical over 28 d, which suggested that the incorporation of chitosan would not compromise the bioresorbability of the CPC. The relationship between the mass loss and the immersion time can be fitted into a linear relationship, i.e.,
where, M L is the mass loss, t is the immersion time, and K is a constant related to the solubility of the material, i.e., mass loss per unit time or dissolution rate. From the curve fitting, the fraction of mass loss per day (%/d) was obtained as 1.05 (R ¼ 99.3) for CPC control and 1.08 (R ¼ 99.9) for CPC-chitosan, which are not significantly different ( p > 0.1). Actually, the dissolution rate of CPC-chitosan became slightly slower with time compared to CPC control, with the ratio of dissolution rates decreasing from 1.23 for the first week (1-7 d) to 0.84 for the fourth week (21-28 d) . Considering the small mass fraction of chitosan in the composite (6.7 wt%), it was suspected that the solubility of chitosanmalate was higher than that of the HA at pH 4.5, which led to the quicker dissolution of composites in the first week.
The CPC control exhibited a relatively smooth surface after 4 weeks of immersion at pH 4.5, indicating a homogenous dissolution of HA (Figure 7 ). However, some large cracks and exfoliations appeared. This may cause the cement to disintegrate/fracture catastrophically in vivo, especially under load bearing situations. In contrast, the microstructure of the CPC composite became relatively rough due to the unequal dissolution of chitosan and CPC. The partially dissolved chitosan matrix and HA crystals formed a porous structure in the surface. Compared to the relatively smooth surface with large cracks and exfoliations for CPC control, the porous CPC composite may be more favorable and stable in vivo as the new bone (osteoblasts) could grow into the porous structure.
SUMMARY
A fast-setting and high-strength calcium phosphate cement was developed by incorporating chitosan malate into the cement liquid at various mass fractions. The cement setting time was reduced from 87 min for the control without chitosan to 13 min at 20% chitosan. Meanwhile, the flexural strength was increased from 4 to 14 MPa. Such substantial improvement in physical and mechanical properties was achieved without severely compromising the resorbability of the cement, as shown in an in vitro dissolution experiment at various pH simulating the acidic environments produced by osteoclasts in vivo. Both the control cement without chitosan and the cement with 20% chitosan were dissolved by nearly 30% for 28 d at a pH of 4.5, indicating that the addition of chitosan to CPC did not compromise the bioresorbability of CPC at this pH. Compared to the formation of large cracks and exfoliations for the CPC control during the 28 d immersion at pH 4.5, the formation of a microporous surface on the CPC-chitosan composite may be beneficial for new bone ingrowth. This new HA-based self-hardening composite with high strength and resorbability may be promising for moderate stress-bearing craniofacial, dental and orthopedic repairs.
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